Mark Dedden



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells (2024) Wiendl M, Dedden M, Liu L, Schweda A, Paap EM, Ullrich K, Hartmann L, et al. Journal article ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo (2024) Schulz-Kuhnt A, Rühle K, Javidmehr A, Döbrönti M, Biwank J, Knittel S, Neidlinger P, et al. Journal article Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease (2023) Schulze L, Becker E, Dedden M, Liu L, Van Passen C, Mohamed Abdou M, Müller T, et al. Journal article Adhesion GPCR Gpr126 (Adgrg6) Expression Profiling in Zebrafish, Mouse, and Human Kidney. (2023) Cazorla-Vázquez S, Kösters P, Bertz S, Pfister F, Daniel C, Dedden M, Zundler S, et al. Journal article Anti-beta 7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing (2023) Sommer K, Heidbreder K, Kreiß L, Dedden M, Paap EM, Wiendl M, Becker E, et al. Journal article, Original article IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells. (2023) Ullrich K, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze L, et al. Journal article Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis (2023) Müller T, Liu L, Czerwinski T, Wiesinger M, Dedden M, Paap EM, Ullrich K, et al. Journal article Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets (2023) Dedden M, Wiendl M, Müller T, Neurath M, Zundler S Journal article Residual homing of alpha 4 beta 7-expressing beta 1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab (2021) Becker E, Dedden M, Gall C, Wiendl M, Ekici AB, Schulz-Kuhnt A, Schweda A, et al. Journal article